These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14687961)

  • 41. Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: what has been the impact of targeted free vaccination?
    Winter RJ; Dietze PM; Gouillou M; Hellard ME; Robinson P; Aitken CK
    J Gastroenterol Hepatol; 2013 Feb; 28(2):314-22. PubMed ID: 23190264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
    Melo LV; da Silva MA; Calçada Cde O; Cavalcante SR; Souto FJ
    Vaccine; 2011 Jul; 29(32):5290-3. PubMed ID: 21605613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serologic examination of hepatitis B infection and immunization in HIV-positive youth and associated risks. The Pediatric AIDS Clinical Trials Group Protocol 220 Team.
    Rogers AS; Lindsey JC; Futterman DC; Zimmer B; Abdalian SE; D'Angelo LJ
    AIDS Patient Care STDS; 2000 Dec; 14(12):651-7. PubMed ID: 11119432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999.
    Santibanez SS; Garfein RS; Swartzendruber A; Kerndt PR; Morse E; Ompad D; Strathdee S; Williams IT; Friedman SR; Ouellet LJ
    Drug Alcohol Depend; 2005 Mar; 77(3):227-33. PubMed ID: 15734222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002.
    Gerlich M; Gschwend P; Uchtenhagen A; Krämer A; Rehm J
    Eur J Epidemiol; 2006; 21(7):545-9. PubMed ID: 16858622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination.
    Ni YH; Chang MH; Huang LM; Chen HL; Hsu HY; Chiu TY; Tsai KS; Chen DS
    Ann Intern Med; 2001 Nov; 135(9):796-800. PubMed ID: 11694104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The significance of the isolated anti-HBc carrier. A study of 1797 drug addicts. The Intersert Group of Scientific Collaboration].
    Mezzelani P; Quaglio G; Venturini L; Lugoboni F
    Recenti Prog Med; 1994 Sep; 85(9):419-24. PubMed ID: 7938872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.
    Neaigus A; Gyarmathy VA; Zhao M; Miller M; Friedman SR; Des Jarlais DC
    J Infect Dis; 2007 Apr; 195(7):1052-61. PubMed ID: 17330797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis B virus serum profiles in injection drug users and rates of immunization over time in Barcelona: 1987-2006.
    Rivas I; Martinez E; Sanvisens A; Bolao F; Tor J; Torrens M; Pujol R; Fuster D; Rey-Joly C; Muñoz A; Muga R
    Drug Alcohol Depend; 2010 Aug; 110(3):234-9. PubMed ID: 20456873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco.
    Lum PJ; Hahn JA; Shafer KP; Evans JL; Davidson PJ; Stein E; Moss AR
    J Viral Hepat; 2008 Mar; 15(3):229-36. PubMed ID: 18233994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decline in Herpes Simplex Virus Type 2 Among Non-Injecting Heroin and Cocaine Users in New York City, 2005 to 2014: Prospects for Avoiding a Resurgence of Human Immunodeficiency Virus.
    Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Tross S; Perlman DC; Campbell AN; Hagan H; Cooper HL
    Sex Transm Dis; 2017 Feb; 44(2):85-90. PubMed ID: 27898577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
    Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
    World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville.
    Vallejo F; Toro C; de la Fuente L; Brugal MT; Soriano V; Silva TC; Bravo MJ; Ballesta R; Barrio G;
    Eur Addict Res; 2008; 14(3):116-24. PubMed ID: 18552487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors associated with hepatitis B vaccination among men having sexual relations with men in Montreal, Quebec, Canada. Omega Study Group.
    Dufour A; Remis RS; Alary M; Otis J; Mâsse B; Turmel B; Vincelette J; Lavoie R; LeClerc R; Parent R
    Sex Transm Dis; 1999 Jul; 26(6):317-24. PubMed ID: 10417018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
    Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E
    Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B surface antibodies in medical students from a public university in Puebla, Mexico.
    Cárdenas-Perea ME; Gómez-Conde E; Santos-López G; Pérez-Contreras I; Díaz-Orea MA; Gándara-Ramírez JL; Cruz Y López OR; Márquez-Domínguez L; Sosa-Jurado F
    Hum Vaccin Immunother; 2016 Jul; 12(7):1857-62. PubMed ID: 27171749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
    J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.